ARRHYTHMOTECH

Medtech · Private

A non-invasive skin electrode instrument for simultaneous recording of sympathetic nerve activity and electrocardiogram (neuECG) to predict and detect cardiac arrhythmias

Grants
$2.9M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase II · Skin Sympathetic Nerve Activity and Cardiac Arrhythmias$775,400
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase II · Skin Sympathetic Nerve Activity and Cardiac Arrhythmias$1,472,476
Federal grantDepartment of Health and Human Services · Phase II · Skin Sympathetic Nerve Activity and Cardiac Arrhythmias$697,076
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1114MOBILE SENSE TECHNOLOGIES, INC.—$500K
1115Mate Fertility, Inc.—$5.7M
1116Optima Neuroscience, Inc.—$593K
1117ARRHYTHMOTECH——
1118Cast21, Inc.—$615K
1119iBac Holdings LLC—$50K
1120Fresenius Medical Care LaPlace, LLC—$1.9M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.